| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/14/1990 | EP0354522A1 Use of alpha-aminoboronic acid derivatives in prevention and treatement of viral diseases |
| 02/14/1990 | EP0354507A2 Process for producing des-B30 insulins and derivatives thereof |
| 02/14/1990 | EP0354504A2 Hybrid protein C constructs and methods for their preparation |
| 02/14/1990 | EP0354492A2 Preparing process of physiologically active substance with anticancer effect and substance obtained thereby |
| 02/14/1990 | EP0354354A2 Process for concentrating blood coagulation factors II, VII, IX en X |
| 02/14/1990 | EP0354278A1 Antibiotic production |
| 02/14/1990 | CN1039597A Neurokinin a antagonists |
| 02/14/1990 | CN1039596A Retroviral protease binding peptides |
| 02/13/1990 | US4900837 Brain-specific drug delivery of steroid sex hormones cleaved from pyridinium carboxylates and dihydro-pyridine carboxylate precursors |
| 02/13/1990 | US4900816 Hemoglobin complexes |
| 02/13/1990 | US4900811 Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mRNAs, receptors, methods and diagnostics using the same |
| 02/13/1990 | US4900780 Acellular resuscitative fluid |
| 02/13/1990 | US4900747 Method and agents for removing advanced glycosylation endproducts |
| 02/13/1990 | US4900720 Plasmapheresis |
| 02/13/1990 | US4900719 Nitrosothiols as hypotensive agents |
| 02/13/1990 | US4900673 Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression |
| 02/13/1990 | CA1265900A1 Peptides aiding nerve regeneration |
| 02/13/1990 | CA1265899A1 Peptides and their use in therapy |
| 02/13/1990 | CA1265898A1 Peptides and processes for preparing the same |
| 02/08/1990 | WO1990001066A1 Porcine polyclonal and monoclonal antibodies |
| 02/08/1990 | WO1990001063A1 New secretory leader sequences |
| 02/08/1990 | WO1990001039A1 Nonglycosylated human interleukin-3 compositions |
| 02/08/1990 | WO1990001038A1 Human insulin analogs and preparations containing them |
| 02/08/1990 | WO1990001037A1 Irreversible peptide ligands for bombesin receptors |
| 02/08/1990 | WO1990001035A1 Cytotoxic agent against specific virus infection |
| 02/08/1990 | WO1990000903A1 Method and compositions for the treatment and prevention of septic shock |
| 02/08/1990 | WO1990000902A1 Monoclonal antibodies reactive with cachectin |
| 02/08/1990 | WO1990000900A1 Method of treating inflammatory disorders by reducing phagocyte activation |
| 02/08/1990 | WO1990000899A1 Compositions and methods for treating skin conditions and promoting wound healing |
| 02/08/1990 | WO1989009788A3 Biosynthetic osteogenic proteins and osteogenic devices containing them |
| 02/08/1990 | WO1989009787A3 Osteogenic devices |
| 02/08/1990 | DE3821757A1 Polypeptides, their preparation and use |
| 02/07/1990 | EP0354108A1 Amino acids and peptides with a modified tyrosine, their preparation and their use as medicines |
| 02/07/1990 | EP0354042A2 Aminobenzoic-acid derivatives to reduce side effects induced by an administration of immuno-suppressant |
| 02/07/1990 | EP0353938A1 Process for producing neuraminidase |
| 02/07/1990 | EP0353910A2 Human interferon-gamma, process for preparing said human interferon-gamma, and its use |
| 02/07/1990 | EP0353861A1 Angiogenesis inhibitor |
| 02/07/1990 | EP0353809A1 Pseudorabies virus vaccine |
| 02/07/1990 | EP0353780A2 Factor for the activation of target cells |
| 02/07/1990 | EP0353772A2 Psoriasis treatment with TGF-beta2 |
| 02/07/1990 | EP0353732A2 Fluoro-olefins, method for their preparation and their use |
| 02/07/1990 | EP0353565A1 Immunostimulating peptides, a process for their preparation and pharmaceutical commpositions containing them |
| 02/07/1990 | EP0353516A2 A method for the preparation of recombinant human beta interleukin-1 in the homogeneous form |
| 02/07/1990 | CN1039440A Tissue plasminogen activator analogue |
| 02/06/1990 | USH734 Method for inhibiting onset of or treating migraine headaches employing an ACE inhibitor |
| 02/06/1990 | US4898931 Novel human interferon-γ polypeptide derivative |
| 02/06/1990 | US4898930 Peptide derivatives and processes for their preparation |
| 02/06/1990 | US4898879 Nurtitional composition for management of hepatic failure |
| 02/06/1990 | US4898857 Treating control nervous system diseases |
| 02/06/1990 | US4898856 Method for treating central nervous system diseases |
| 02/06/1990 | US4898826 Method to solubilize tissue plasminogen activator |
| 02/06/1990 | US4898825 Methods for purification of single-chain and double-chain tissue plasminogen activator |
| 02/06/1990 | US4898818 Antitumor active substance, process for preparing the same, drug containing the substance, gene coding for the substance, vector containing the gene and recombinant microorganism |
| 02/06/1990 | US4898815 Diagnostic serum from rabbit treated with polypeptide kit to detect cholera or escherichia |
| 02/06/1990 | US4898814 A cDNA clone for human tyrosinase |
| 02/06/1990 | US4898732 Inhibiting of tumor growth with an antagonist of the renin-angioten-sin system |
| 02/06/1990 | US4898730 Method to stimulate the immune response to specific antigens |
| 02/06/1990 | CA1265650A1 Method for purifying a physiologically active substance produced by recombinant dna technique |
| 02/06/1990 | CA1265649A1 Peptide antibodies and their use in detecting oncogene products |
| 02/06/1990 | CA1265446A1 Anticoagulating substance, process for preparing same and anticoagulant comprising same as an effective component |
| 02/06/1990 | CA1265445A1 Composition for use in treating inflammation |
| 02/06/1990 | CA1265444A1 Effect of human tumor necrosis factor and human interferon on human cancer cells and methods |
| 01/31/1990 | EP0353218A2 Method of producing lysplasminogen |
| 01/31/1990 | EP0353211A1 New compounds |
| 01/31/1990 | EP0353150A1 Recombinant non-glycosylated human IL2 in reduced form, process for its production and its medical use |
| 01/31/1990 | EP0353111A1 Nucleic acid or fragments thereof encoding the P30 protein of Toxoplasma gondii, methods for their preparation and uses thereof |
| 01/31/1990 | EP0353045A2 Devices and methods for growth promotion in poultry roasters |
| 01/31/1990 | EP0353018A1 Intraocular anticoagulant |
| 01/31/1990 | EP0352904A1 Tissue plasminogen activator analogues |
| 01/31/1990 | EP0352903A2 Bovine factor Xa inhibiting factor and pharmaceutical compositions containing the same |
| 01/31/1990 | EP0352897A1 TPA-containing medicaments |
| 01/31/1990 | EP0352816A2 IL-1alpha derivates and medicament for treating thrombocytopenia |
| 01/31/1990 | EP0352761A2 Antigens composed of "major histocompatibility complex" class I antigens and specific carrier molecules, their production and use |
| 01/31/1990 | EP0352722A2 Adenocarcinoma antigen binding methods and reagents |
| 01/31/1990 | EP0352710A2 t-PA derivative and its production |
| 01/31/1990 | EP0352707A2 An expression system for the secretion of bioactive human granulocyte macrophage colony stimulating factor (GM-CSF) and other heterologous proteins from streptomyces |
| 01/31/1990 | EP0352651A1 Human protein C mutants and method for preparing the same |
| 01/31/1990 | EP0352646A2 FR901228 Substance and preparation thereof |
| 01/31/1990 | EP0352560A1 Novel peptides |
| 01/31/1990 | EP0352538A2 Amides of N15-alkyl and N15,N15-dialkyl teicoplanin derivatives |
| 01/31/1990 | EP0352500A2 Method for the production of a polyclonal immunoglobulin-based intravenous preparation with a high IgM content . |
| 01/31/1990 | EP0135181B1 Process for the production of n-alkylated dipeptides and of their esters |
| 01/30/1990 | US4897489 Antibiotic derivatives, their production and use |
| 01/30/1990 | US4897483 Amino acid derivatives as antihypertensives |
| 01/30/1990 | US4897471 Consensus human leukocyte interferon |
| 01/30/1990 | US4897466 Human lymphoblastoid cell line and hybridomas derived therefrom |
| 01/30/1990 | US4897463 Glycine and glutamic acid hexapeptide |
| 01/30/1990 | US4897389 Using estrogenic hormones |
| 01/30/1990 | US4897379 N-[N.sup.α -(1(S)-carboxy-3-cyclohexylpropyl)-L-lysyl]-N-cyclopentylglycine as antihypertensives |
| 01/30/1990 | US4897348 Recombinant materials and methods for producing human connective tissue-activating peptide-III and analogs thereof |
| 01/30/1990 | US4897268 Drug delivery system and method of making the same |
| 01/30/1990 | US4897264 Human gamma interferon-specific receptor protein, antibody against said protein, methods for obtaining said protein and said antibody and compositions containing said protein and antibody |
| 01/30/1990 | US4897263 Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids |
| 01/30/1990 | US4897256 Aerosols |
| 01/30/1990 | US4897252 Production of hydrogen peroxide |
| 01/30/1990 | CA1265053A1 Method for preventing or alleviating skin irritation by formulations containing superoxide dismutase |
| 01/30/1990 | CA1265052A1 Absorption enhancing agents |
| 01/30/1990 | CA1265051A1 Pasteurized, isoagglutinin-free factor viii preparation and a process for its production |
| 01/30/1990 | CA1265050A1 Purification of blood clotting factors and other blood proteins on non-carbohydrate sulfated matrices |
| 01/30/1990 | CA1265009A1 Initiating reperfusion treatment when heart attack symptoms are present |